Lawfirm | Lawyer

Hogan Lovells announced today that it advised Lyons, France-based drug delivery technology company Flamel Technologies (NASDAQ: FLML) on its acquisition of Éclat Pharmaceuticals, a specialty pharmaceutical company based in St. Louis, MO focused on the development, approval and commercialization of niche brands and generic products. Éclat Pharmaceuticals previously was owned by an affiliate of Deerfield Capital L.P., a leading life sciences industry investor.

The Atlanta office of Greenberg Traurig, LLP announces that Joe D. Whitley, Shareholder and Chair of the Atlanta White Collar Litigation Practice Group, will be a presenter at the American Bar Association’s 22nd Annual National Institute on Health Care Fraud. The conference will take place May 9-11, 2012 at the Encore at Wynn Las Vegas.

In an order dated March 31, 2012, Judge Paul Gardephe of the Southern District of New York granted J.P. Morgan Securities LLC’s motion to dismiss federal securities fraud claims brought on behalf of a putative class of purchasers of auction rate securities (ARS) over a nearly four-year period. The suit related to the widespread failures of auctions for ARS in February 2008 as a result of which many investors were unable to sell their securities at auction.